XML 120 R77.htm IDEA: XBRL DOCUMENT v3.20.4
Investments - Additional Information (Detail) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Schedule Of Available For Sale Securities [Line Items]      
Realized loss on equity investments $ (2,440,000) $ 0  
Unrealized losses on equity Investments 4,283,000 939,000  
Investment in joint venture under the equity method 9,300,000 11,448,000  
Property and equipment, net $ 199,559,000 $ 184,217,000  
Anheuser-Busch InBev [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Percentage of ownership 50.00%    
Percentage of voting interest 50.00%    
Fluent [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Percentage of ownership 50.00% 50.00%  
Investment in joint venture under the equity method $ 5,291,000 $ 7,836,000  
Fluent [Member] | Joint Venture [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Percentage of ownership 50.00%    
Percentage of voting interest 50.00%    
Investment in joint venture under the equity method $ 3,764,000 12,000,000 $ 0
Payments to acquire equipment   4,300,000  
Property and equipment, net   4,300,000  
Total fees charged 4,113,000 388,000  
Fluent [Member] | Joint Venture [Member] | Accounts Payable [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Total fees charged $ 674,000 $ 388,000  
Cannfections [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Percentage of ownership 50.00% 50.00%  
Investment in joint venture under the equity method $ 4,009,000 $ 3,612,000  
Cannfections [Member] | Joint Venture [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Percentage of ownership 50.00%    
Percentage of voting interest 50.00%    
Investment in joint venture under the equity method $ 0 3,600,000  
Expenses for purchases $ 436,000 84,000  
Cannfections [Member] | Joint Venture [Member] | Cash [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Investment in joint venture under the equity method   1,901,000  
Cannfections [Member] | Joint Venture [Member] | Class 2 Common Stock [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Investment in joint venture under the equity method   $ 1,699,000  
Convertible Debt Instrument [Member]      
Schedule Of Available For Sale Securities [Line Items]      
Convertible debt instruments with interest rates 10.00%    
Convertible debt instruments contractual maturity 2022    
Convertible debt instruments settlement amount $ 2,500,000